A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia

Herranz, Daniel, Ambesi-Impiombato, Alberto, Palomero, Teresa, Schnell, Stephanie A, Belver, Laura, Wendorff, Agnieszka A, Xu, Luyao, Castillo-Martin, Mireia +5 more·2014·Nature Medicine

DOI 10.1038/nm.3665

Cited by (405)

Items 201–300 of 405

Preclinical Models Provide Scientific Justification and Translational Relevance for Moving Novel Therapeutics into Clinical Trials for Pediatric Cancer
David M. Langenau, Alejandro Sweet-Cordero, Robert J. Wechsler‐Reya, Michael A. Dyer · 2015 · Cancer Research
ChIP-seq in Studying Epigenetic Mechanisms of Disease and Promoting Precision Medicine: Progresses and Future Directions
Huihuang Yan, Shulan Tian, Susan L. Slager, Zhifu Sun · 2016 · Epigenomics
A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia
Luca Tottone, Olga Lancho, Jui-Wan Loh, Amartya Singh, Shunsuke Kimura, Juliette Roels, Anna A. Kuchmiy, Steven Strubbe, Matthew A. Lawlor, Victoria da Silva-Diz et al. · 2020 · Blood Cancer Discovery
The molecular understanding of super-enhancer dysregulation in cancer.
Seiko Yoshino, Hiroshi I. Suzuki · 2022 · PubMed Central
ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia
Rohan Kodgule, Joshua W. Goldman, Alexander C. Monovich, Travis W. Saari, Athalee R. Aguilar, Cody N. Hall, Niharika Rajesh, Juhi Gupta, Alec Chu, Li Ye et al. · 2022 · Blood Cancer Discovery
c‐Myc‐Induced Survivin Is Essential for Promoting the Notch‐Dependent T Cell Differentiation from Hematopoietic Stem Cells
Rizwanul Haque, Jianyong Song, Mohammad Mahfuzul Haque, Fengyang Lei, Praneet Sandhu, Bing Ni, Song Guo Zheng, Deyu Fang, Jinming Yang, Jianxun Jim Song · 2017 · Genes
4See: A Flexible Browser to Explore 4C Data
Yousra Ben Zouari, A. Platania, Anne Molitor, Tom Sexton · 2020 · Frontiers in Genetics
Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies
Sonia M. Debek, Przemysław Juszczyński · 2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Recent advances in understanding the role of HES6 in cancers
Imène Krossa, Thomas Strub, Arnaud Martel, Sacha Nahon‐Estève, Sandra Lassalle, Paul M Hofman, Stéphanie Baillif, Robert Ballotti, Corine Bertolotto · 2022 · Theranostics
Super-Enhancers and Their Parts: From Prediction Efforts to Pathognomonic Status
Anastasia V. Vasileva, Marina G. Gladkova, German A. Ashniev, Ekaterina D. Osintseva, А. В. Орлов, Ekaterina V. Kravchuk, Anna Boldyreva, Alexandr G. Burenin, Petr Ivanovich Nikitin, Natalia N. Orlova · 2024 · International Journal of Molecular Sciences
Amplified dosage of the NKX2-1 lineage transcription factor controls its oncogenic role in lung adenocarcinoma
John L. Pulice, Matthew M. Meyerson · 2023 · Molecular Cell
Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia
Meng-Ping Xi, Shanshan Guo, Caicike Bayin, Lijun Peng, Florent Chuffart, Ekaterina Bourova-Flin, Sophie Rousseaux, Saadi Khochbin, Jian‐Qing Mi, Jin Wang · 2021 · Frontiers of Medicine
Super-enhancer associated core regulatory circuits mediate susceptibility to retinoic acid in neuroblastoma cells
Roshna Lawrence Gomez, Laura M. Woods, Revathy Ramachandran, Ahmad N. Abou Tayoun, Anna Philpott, Fahad R. Ali · 2022 · Frontiers in Cell and Developmental Biology
Reversible Myc hypomorphism identifies a key Myc-dependency in early cancer evolution
Nicole M. Sodir, Luca Pellegrinet, Roderik M. Kortlever, Tania Campos, Yong-Won Kwon, Shinseog Kim, Daniel A. Garcia, Alessandra Perfetto, Panayiotis Anastasiou, Lamorna Brown Swigart et al. · 2022 · Nature Communications
Controlling the Master: Chromatin Dynamics at the MYC Promoter Integrate Developmental Signaling
Olga Zaytseva, Leonie M. Quinn · 2017 · Genes
Wee1 kinase inhibitor MK‑1775 induces apoptosis of acute lymphoblastic leukemia cells and enhances the efficacy of doxorubicin involving downregulation of Notch pathway
Yanchao Duan, Xin Yu Dong, Jing Nie, Peng Li, Fei Lu, Daoxin Ma, Chunyan Ji · 2018 · Oncology Letters
Combinatorial ETS1-Dependent Control of Oncogenic NOTCH1 Enhancers in T-cell Leukemia
Anna C. McCarter, Giusy Della Gatta, Ashley F. Melnick, Erin J. Kim, Cher Sha, Qing Wang, Jahnavi K. Nalamolu, Yiran E. Liu, Theresa M. Keeley, Ran Yan et al. · 2020 · Blood Cancer Discovery
Co-targeting of Tiam1/Rac1 and Notch ameliorates chemoresistance against doxorubicin in a biomimetic 3D lymphoma model
Muhammad Ikram, Ye-Seon Lim, Sun‐Yong Baek, Songwan Jin, Young Hun Jeong, Jong-Young Kwak, Sik Yoon · 2017 · Oncotarget
NOTCH1-driven UBR7 stimulates nucleotide biosynthesis to promote T cell acute lymphoblastic leukemia
Shashank Srivastava, Umakant Sahu, Yalu Zhou, Ann Hogan, Kizhakke Mattada Sathyan, Justin Bodner, Jiehuan Huang, Kelvin A. Wong, Natalia Khalatyan, Jeffrey N. Savas et al. · 2021 · Science Advances
Multiple Mechanisms of NOTCH1 Activation in Chronic Lymphocytic Leukemia: NOTCH1 Mutations and Beyond
Federico Pozzo, Tamara Bittolo, Erika Tissino, Antonella Zucchetto, Riccardo Bomben, Laura Polcik, Svenja Dannewitz Prosseda, Tanja Nicole Hartmann, Valter Gattei · 2022 · Cancers
Notch Partners in the Long Journey of T-ALL Pathogenesis
Marı́a L. Toribio, Sara González-García · 2023 · International Journal of Molecular Sciences
KMT2D mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-induced regulatory T cell trafficking via FBXW7-NOTCH-MYC/TGF-β1 axis
Qing-Xiao Liu, Yue Zhu, Hongmei Yi, Yige Shen, Li Wang, Shu Cheng, Pengpeng Xu, Haimin Xu, Luting Zhou, Yao‐Hui Huang et al. · 2024 · International Journal of Biological Sciences
Direct ChIP-Seq significance analysis improves target prediction
Mukesh Bansal, Geetu Mendiratta, Santosh Kumar Anand, Ritu Kushwaha, Hyunjae Ryan Kim, Manjunath Kustagi, Archana P. Iyer, Raju S. K. Chaganti, Andrea Califano, Pavel Sumazin · 2015 · BMC Genomics
Zebrafish models of leukemia
Shuning He, Changbin Jing, Alfred Thomas Look · 2017 · Methods in cell biology
Exploring MYC relevance to cancer biology from the perspective of cell competition
Simona Paglia, Manuela Sollazzo, Simone Di Giacomo, Silvia Strocchi, Daniela Grifoni · 2019 · Seminars in Cancer Biology
Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC
Jiarong Bao, Man Li, Shumei Liang, Yunchu Yang, Jingfang Wu, Qingqing Zou, Shun Fang, Size Chen, Linlang Guo · 2019 · BMC Medical Genomics
Homoharringtonine inhibits the NOTCH/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia
Shanshan Suo, Dandan Zhao, Fenglin Li, Yi Zhang, Sonia Rodrı́guez, Le Xuan Truong Nguyen, Lucy Y. Ghoda, Nadia Carlesso, Guido Marcucci, Bin Zhang et al. · 2024 · Blood
α-Ketoglutarate-Mediated DNA Demethylation Sustains T-Acute Lymphoblastic Leukemia upon TCA Cycle Targeting
Yanwu Wang, Ning Shen, Gervase Spurlin, Sovannarith Korm, Sarah X.L. Huang, Nicole M. Anderson, Leah N. Huiting, Hudan Liu, Hui Feng · 2022 · Cancers
Interpretation of the role of germline and somatic non-coding mutations in cancer: expression and chromatin conformation informed analysis
Michael Pudjihartono, Jo Kate Perry, Cristin Gregor Print, Justin Martin O'Sullivan, William S. Schierding · 2022 · Clinical Epigenetics
A Therapeutically Targetable NOTCH1–SIRT1–KAT7 Axis in T-cell Leukemia
Olga Lancho, Amartya Singh, Victoria da Silva-Diz, Luca Tottone, Patrícia Renck Nunes, Maya Aleksandrova, Jesminara Khatun, Shirley Luo, Caifeng Zhao, Haiyan Zheng et al. · 2022 · Blood Cancer Discovery
Three‐dimensional genome structure and function
Hao Liu, Hsiangyu Tsai, Maoquan Yang, Guozhi Li, Qian Bian, Gang Ding, Dandan Wu, Jiewen Dai · 2023 · MedComm
The Biology of SUMO-Targeted Ubiquitin Ligases in Drosophila Development, Immunity, and Cancer
Mona Abed, Eliya Bitman-Lotan, Amir Orian · 2018 · Journal of Developmental Biology
Differentially Methylated Super-Enhancers Regulate Target Gene Expression in Human Cancer
Emily L. Flam, Ludmila Danilova, Dylan Z. Kelley, Elena D. Stavrovskaya, Theresa W. Guo, Michael Considine, Jiang X. Qian, Joseph A. Califano, Alexander V. Favorov, Elana Judith Fertig et al. · 2019 · Scientific Reports
Case Report: Early Distant Metastatic Inflammatory Myofibroblastic Tumor Harboring EML4-ALK Fusion Gene: Study of Two Typical Cases and Review of Literature
Qianqian Han, Xin He, Lijuan Cui, Yan Qiu, Yuli Li, Huijiao Chen, Hongying Zhang · 2022 · Frontiers in Medicine
Molecular Biology of Childhood Leukemia
Thomas Alexander, Charles Grenfell Mullighan · 2020 · Annual Review of Cancer Biology
Super enhancers: Pathogenic roles and potential therapeutic targets for acute myeloid leukemia (AML)
Ziyang Cao, Yi Shu, Jinxia Wang, Chunxia Wang, Tienan Feng, Yang Li, Jingbo Shao, Lin Zou · 2022 · Genes & Diseases
Insights into the Links between MYC and 3D Chromatin Structure and Epigenetics Regulation: Implications for Cancer Therapy
Fatemeh Amjadi‐Moheb, Alireza Paniri, Haleh Akhavan‐Niaki · 2021 · Cancer Research
Multi-modular structure of the gene regulatory network for specification and commitment of murine T cells
Boyoung Shin, Ellen V. Rothenberg · 2023 · Frontiers in Immunology
Distinct use of super-enhancer elements controls cell type–specific CD25 transcription and function
Rosanne J. Spolski, Peng Li, Vivek Chandra, Boyoung Shin, Shubham Goel, Keiko Sakamoto, Chengyu Liu, Jangsuk Oh, Min Ren, Yutaka Enomoto et al. · 2023 · Science Immunology
Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Clement Chung, Hilary Ma · 2017 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Immunohistochemical Profile of MYC Protein in Pediatric Small Round Blue Cell Tumors
Karen M. Chisholm, Chandra Krishnan, Amy Heerema‐McKenney, Yasodha Natkunam · 2017 · Pediatric and Developmental Pathology
Epigenetics in Hematological Malignancies
Nataly Cruz-Rodríguez, Alba Lucía Cómbita, Jovanny Zabaleta · 2018 · Methods in molecular biology
The role of noncoding mutations in blood cancers
Sunniyat Rahman, Marc R. Mansour · 2019 · Disease Models & Mechanisms
Controlling gene activation by enhancers through a drug-inducible topological insulator
Taro Tsujimura, Osamu Takase, Masahiro Yoshikawa, Etsuko Sano, Matsuhiko Hayashi, Kazuto Hoshi, Tsuyoshi Takato, Atsushi Toyoda, Hideyuki Okano, Keiichi Hishikawa · 2020 · eLife
Genomic context sensitivity of insulator function
André Mauricio Ribeiro-dos-Santos, Megan S. Hogan, Raven D. Luther, Ran Brosh, Matthew T. Maurano · 2022 · Genome Research
CRISPR Screening of Transcribed Super-Enhancers Identifies Drivers of Triple-Negative Breast Cancer Progression
Michael W. Lewis, Caitlin M. King, Kamila Wiśniewska, Matthew J. Regner, Alisha R. Coffey, Michael R. Kelly, Raúl Méndez-Giráldez, Eric S. Davis, Douglas H. Phanstiel, Hector L. Franco · 2024 · Cancer Research
Myc activity is required for maintenance of the neuromesodermal progenitor signalling network and for segmentation clock gene oscillations in mouse
Ioanna Mastromina, Laure Verrier, Joana Clara Silva, Kate G. Storey, Jacqueline Kim Dale · 2018 · Development
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Judith Schütte, Julia Reusch, Cyrus Khandanpour, Christine Eisfeld · 2019 · Frontiers in Oncology
Revisiting β‐Catenin Signaling in T‐Cell Development and T‐Cell Acute Lymphoblastic Leukemia
Anna Bigas, Yolanda Guillén, Leonie Schoch, David Arambilet · 2019 · BioEssays
Notch Signaling and Human Papillomavirus–Associated Oral Tumorigenesis
Trinath Prasad Das, Rong Zhong, Michael T. Spiotto · 2020 · Advances in experimental medicine and biology
Super-Enhancers in the Regulation of Gene Transcription: General Aspects and Antitumor Targets
Alexandra V. Bruter, Mariya D. Rodionova, Ekaterina A. Varlamova, Alexander Albertovich Shtil · 2021 · Acta Naturae
MYC deficiency impairs the development of effector/memory T lymphocytes
Mathis Nozais, Marie Loosveld, Saran Pankaew, Clémence Grosjean, Gentil Noemie, Julie Quessada, Bertrand Nadel, Cyrille Mionnet, Delphine Potier, Dominique Payet‐Bornet · 2021 · iScience
Mapping and making sense of non-coding mutations in the genome.
Jiekun Yang, Mazhar Adli · 2019 · Cancer Research
Deciphering the Complexity of 3D Chromatin Organization Driving Lymphopoiesis and Lymphoid Malignancies
Laurianne Scourzic, Eralda Salataj, Effie Apostolou · 2021 · Frontiers in Immunology
The Interplay of Transcription and Genome Topology Programs T Cell Development and Differentiation
Xin Zhao, Shaoqi Zhu, Weiqun Peng, Hai‐Hui Xue · 2022 · The Journal of Immunology
MYCN Amplification Is Associated with Reduced Expression of Genes Encoding γ-Secretase Complex and NOTCH Signaling Components in Neuroblastoma
Prasoon Agarwal, Aleksandra Glowacka, Loay Mahmoud, Wesam Bazzar, Lars‐Gunnar Larsson, Mohammad Alzrigat · 2023 · International Journal of Molecular Sciences
The BET inhibitor GNE-987 effectively induces anti-cancer effects in T-cell acute lymphoblastic leukemia by targeting enhancer regulated genes
Juanjuan Yu, Yang Yang, Rongfang Zhou, Yanfang Tao, Frank Zhu, Wanyan Jiao, Zi-Mu Zhang, Tongting Ji, Tiandan Li, Fang Fang et al. · 2024 · Carcinogenesis
RUNX1 C-terminal mutations impair blood cell differentiation by perturbing specific enhancer-promoter networks
Nathan D. Jayne, Zhengyu Liang, Do‐Hwan Lim, Poshen B. Chen, Cristina Diaz, Kei‐ichiro Arimoto, Lingbo Xia, Mengdan Liu, Bing Ren, Xiang‐Dong Fu et al. · 2024 · Blood Advances
A feedforward loop between ACLY and MYC supports T-ALL progression in vivo
Victoria da Silva-Diz, Amartya Singh, Maya Aleksandrova, Oekyung Kim, Christopher Thai, Olga Lancho, Patrícia Renck Nunes, Hayley C. Affronti, Alexia Martínez de Paz, Steven Zvi Josefowicz et al. · 2025 · Blood Neoplasia
Long-range gene regulation and novel therapeutic applications
Anita van den Heuvel, Ralph Stadhouders, Charlotte Andrieu‐Soler, Frank G. Grosveld, Éric Soler · 2015 · Blood
Therapeutic target discovery and drug development in cancer stem cells for leukemia and lymphoma: from bench to the clinic
Angelo B. A. Laranjeira, Sherry X. Yang · 2016 · Expert Opinion on Drug Discovery
Genome-Wide Approaches to Defining Macrophage Identity and Function
Gregory J. Fonseca, Jason S. Seidman, Christopher K. Glass · 2016 · Microbiology Spectrum
Notch1 Phase Separation Coupled Percolation facilitates target gene expression and enhancer looping
Foran, Gregory, Hallam, Ryan Douglas, Megaly, Marvel, Turgambayeva, Anel, Antfolk, Daniel, Li, Yifeng, Luca, Vincent C., Necakov, Aleksandar · 2024 · Scientific Reports
Deregulation of enhancer structure, function, and dynamics in acute lymphoblastic leukemia
Laura Belver, Robert Alberó, Adolfo A. Ferrando · 2021 · Trends in Immunology
Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers
Laura Vízkeleti, Sándor Spisák · 2023 · Cells
Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells
Н. М. Тодосенко, Kristina Alekseevna Yurova, Хазиахматова Ольга Геннадьевна, Vladimir Vladimirovich Malashchenko, И. А. Хлусов, Larisa Sergeevna Litvinova · 2022 · Pharmaceutics
A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia
Valeria Tosello, Gloria Milani, Annalisa Martines, N Macrì, Wouder Van Loocke, Filip Matthijssens, Barbara Buldini, Sonia Anna Minuzzo, Deborah Bongiovanni, Richard Fabian Schumacher et al. · 2018 · Cells
Transcriptional regulation of MYC through G-quadruplex structures
Sumirtha Balaratnam, John S. Schneekloth · 2020 · Annual reports in medicinal chemistry
In vivo interrogation of regulatory genomes reveals extensive quasi-insufficiency in cancer evolution
Anja Fischer, Robert Lersch, Niklas de Andrade Krätzig, Alexander J. Strong, Mathias Friedrich, Julia Weber, Thomas Engleitner, Rupert Öllinger, Hsi-Yu Yen, Ursula Kohlhofer et al. · 2023 · Cell Genomics
Oncogenic Enhancers in Leukemia
Roger Mulet‐Lazaro, Ruud Delwel · 2024 · Blood Cancer Discovery
Smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma Cells via Crosstalk with Notch1
Yihao Zhu, Handong Wang, Maoxing Fei, Ting Fang Tang, Wenhao Niu, Li Zhang · 2020 · Molecular Neurobiology
Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL
Mateusz Antoszewski, Nadine Fournier, Gustavo A. Ruiz Buendía, João Lourenço, Yuanlong Liu, Tara Sugrue, Christelle Dubey, Marianne Nkosi, Colin E.J. Pritchard, Ivo Johan Huijbers et al. · 2022 · Blood
Oncogenic Runx1–Myc axis in p53-deficient thymic lymphoma
Yuki Date, Ichiro Taniuchi, Kosei Ito · 2022 · Gene
MYC as therapeutic target in leukemia and lymphoma
Javier León, María G. Cortiguera, Ana Batlle‐López, Marta Albajar, M. Dolores Delgado · 2015 · Blood and Lymphatic Cancer Targets and Therapy
Principles and methods of integrative chromatin analysis in primary tissues and tumors
Paloma Cejas, Henry W. Long · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Cancer regulatory variation
Rebecca C. Hennessey, Kevin M Brown · 2021 · Current Opinion in Genetics & Development
Integrating the Epigenome and Transcriptome of Hepatocellular Carcinoma to Identify Systematic Enhancer Aberrations and Establish an Aberrant Enhancer-Related Prognostic Signature
Peng Huang, Bin Zhang, Junsheng Zhao, Ming D. Li · 2022 · Frontiers in Cell and Developmental Biology
An integrated transcriptional switch at the β-selection checkpoint determines T cell survival, development and leukaemogenesis
Anchi S. Chann, Sarah May Russell · 2019 · Biochemical Society Transactions
TAL1 hijacks MYCN enhancer that induces MYCN expression and dependence on mevalonate pathway in T-cell acute lymphoblastic leukemia
Shi Hao Tan, Tze King Tan, Rui Yokomori, Minghui Liao, Xiao Zi Huang, Allen Eng Juh Yeoh, Takaomi Sanda · 2023 · Leukemia
PIM1 is a potential therapeutic target for the leukemogenic effects mediated by JAK/STAT pathway mutations in T-ALL/LBL
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, Pilar Llamas, José Luis López Lorenzo, Javier Cornago, Javíer Santos, José Fernández‐Piqueras, María Villa‐Morales · 2024 · npj Precision Oncology
More than Just Protein Folding: The Epichaperome, Mastermind of the Cancer Cell
Haneef Ahmed Amissah, Maxwell Hubert Antwi, Tawfeek Ahmed Amissah, Stephanie Elisabeth Combs, Maxim Alekseevich Shevtsov · 2025 · Cells
Comprehensive dissection of cis-regulatory elements in a 2.8 Mb topologically associated domain in six human cancers
Christina M. Caragine, Victoria T. Le, Meer Mustafa, Bianca Jay Diaz, John A. Morris, Simon Müller, Alejandro Méndez‐Mancilla, Evan T. Geller, Noa Liscovitch‐Brauer, Neville E. Sanjana · 2025 · Nature Communications
TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas
Edgar González-Buendía, Junfei Zhao, Lu Wang, Subhas Mukherjee, Daniel Yang Zhang, Victor Andrés Arrieta, Eric Feldstein, JOSHUA ROBERT KANE, Seong Jae Kang, Catalina Lee-Chang et al. · 2021 · Clinical Cancer Research
TooManyPeaks identifies drug-resistant-specific regulatory elements from single-cell leukemic epigenomes
Gregory W. Schwartz, Yeqiao Zhou, Jelena Petrovic, Warren S. Pear, Robert B. Faryabi · 2021 · Cell Reports
Histone chaperone ASF1A accelerates chronic myeloid leukemia blast crisis by activating Notch signaling
Xiaolin Yin, Minran Zhou, Lu Zhang, Yue Fu, Man Xu, Xiaoming Wang, Zelong Cui, Zhenxing Gao, Miao Li, Yuting Dong et al. · 2022 · Cell Death and Disease
γ-Secretase inhibitor–resistant glioblastoma stem cells require RBPJ to propagate
Xing Fan · 2016 · Journal of Clinical Investigation
RUNX1 promotes cell growth in human T-cell acute lymphoblastic leukemia by transcriptional regulation of key target genes
Catherine E. Jenkins, Samuel Gusscott, Rachel J. Wong, Olena O Shevchuk, Gurneet Rana, Vincenzo Giambra, Kateryna Tyshchenko, Rashedul Islam, Martin Hirst, Andrew P. Weng · 2018 · Experimental Hematology
Super-Enhancers Dysregulations in Hematological Malignancies
Yannis Belloucif, Camille Lobry · 2022 · Cells
Enhancers and their dynamics during hematopoietic differentiation and emerging strategies for therapeutic action
Alba Cico, Charlotte Andrieu‐Soler, Éric Soler · 2016 · FEBS Letters
Immune-epigenetic crosstalk in haematological malignancies
Hera Wong, Ryohichi Sugimura · 2023 · Frontiers in Cell and Developmental Biology
Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia
Sunniyat Rahman, Gianna Bloye, Nadine Farah, Jonas Demeulemeester, Joana R. Costa, David O’Connor, Rachael Pocock, Tanya Rapoz-D’Silva, Adam Turňa, Lingyi Wang et al. · 2024 · Blood
Selective Enhancer Dependencies in MYC -Intact and MYC -Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma
Ashwin R. Iyer, Aishwarya Gurumurthy, Alec Chu, Rohan Kodgule, Athalee R. Aguilar, Travis W. Saari, Abdullah Ramzan, Jan Rosa, Juhi Gupta, Arvind Emmanuel et al. · 2025 · Blood Cancer Discovery
Notch1 activation and inhibition in T-cell acute lymphoblastic leukemia subtypes
Jiawen Lu, Xiuhua Xue, Haitao Wang, Ying Hao, Qiong Yang · 2025 · Experimental Hematology
A super-enhancer maintains homeostatic expression of Regnase-1
Riyun Yang, Yuanyuan Wu, Yue Ming, Yuanpei Xu, Shouyan Wang, Jianbo Shen, Chenlu Wang, Xia Chen, Yongming Wang, Renfang Mao et al. · 2018 · Gene
Roles of super enhancers and enhancer RNAs in skeletal muscle development and disease
Si Lei, Cheng Li, Yanling She, Shanyao Zhou, Huacai Shi, Rui Chen · 2022 · Cell Cycle
Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites
Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, Luigi Emilio Xodo, Claudio Brancolini · 2023 · International review of cytology
The DMT1 isoform lacking the iron‐response element regulates normal and malignant hematopoiesis via NOTCH pathway activation
Judith Hounjet, Linde Van Aerschot, Kim De Keersmaecker, Marc Vooijs, Kim Rosalie Kampen · 2024 · FEBS Letters
Enhancers and MYC interplay in hematopoiesis
Leonidas Benetatos, Agapi Benetatou, George Vartholomatos · 2020 · Journal of Molecular Medicine
E Protein Transcription Factors as Suppressors of T Lymphocyte Acute Lymphoblastic Leukemia
Geoffrey Parriott, Barbara L. Kee · 2022 · Frontiers in Immunology
Latest Contributions of Genomics to T-Cell Acute Lymphoblastic Leukemia (T-ALL)
Eulàlia Genescà, Celia González‐Gil · 2022 · Cancers